{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T18:25:19Z","timestamp":1791483919327,"version":"4.3.4"},"reference-count":122,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminarsinnuclearmedicine.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nuclear Medicine"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1053\/j.semnuclmed.2017.10.004","type":"journal-article","created":{"date-parts":[[2017,11,13]],"date-time":"2017-11-13T14:30:32Z","timestamp":1510583432000},"page":"166-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Monitoring Response to Therapy"],"prefix":"10.1053","volume":"48","author":[{"given":"Mike M.","family":"Sathekge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred O.","family":"Ankrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaheel","family":"Lawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"Vorster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061273","article-title":"Hormesis and defense of infectious disease","volume":"18","author":"Weis","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.semnuclmed.2013.04.008","article-title":"FDG-PET imaging in HIV infection and tuberculosis","volume":"43","author":"Sathekge","year":"2013","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1473-3099(08)70256-1","article-title":"Emerging infections: A perpetual challenge","volume":"8","author":"Morens","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1126\/science.288.5464.287","article-title":"Infectious history","volume":"288","author":"Lederberg","year":"2000","journal-title":"Science"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nature02759","article-title":"The challenge of emerging and re-emerging infectious diseases","volume":"430","author":"Morens","year":"2004","journal-title":"Nature"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0035","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1007\/s00134-015-3978-8","article-title":"Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting","volume":"41","author":"Albrich","year":"2015","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0040","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/cc6860","article-title":"Pro\/Con debate: Is procalcitonin useful for guiding antibiotic decision making in critically ill patients?","volume":"12","author":"Shehabi","year":"2008","journal-title":"Crit Care"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0045","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/cc5723","volume":"11","author":"Kofoed","year":"2007","journal-title":"Crit Care"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0050","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2253-14-102","article-title":"Pre-analytic factors and initial biomarker levels in community-acquired pneumonia patients","volume":"14","author":"Kutz","year":"2014","journal-title":"BMC Anesthesiol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0055","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1093\/cid\/ciu732","article-title":"Use of procalcitonin in patients with various degrees of chronic kidney disease including renal replacement therapy","volume":"59","author":"Grace","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0060","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1007\/s00259-012-2179-8","article-title":"FDG PET\/CT is useful for the interim evaluation of response to therapy in patients affected by haematogenous spondylodiscitis","volume":"39","author":"Nanni","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0065","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2967\/jnumed.116.186353","article-title":"Repeatability of SUV in oncologic 18F-FDG PET","volume":"58","author":"Lodge","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.semnuclmed.2007.08.004","article-title":"(18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: An overview of radiochemistry and mechanisms of tumor localization","volume":"37","author":"Vallabhajosula","year":"2007","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s40336-016-0164-0","article-title":"PET\/CT imaging of Mycobacterium tuberculosis infection","volume":"4","author":"Ankrah","year":"2016","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0080","first-page":"623036","article-title":"The use of (18)F-FDG-PET\/CT for diagnosis and treatment monitoring of inflammatory and infectious diseases","author":"Glaudemans","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0085","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40336-015-0159-2","article-title":"Imaging fungal infections in children","volume":"4","author":"Ankrah","year":"2016","journal-title":"Clin Transl Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0090","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.semnuclmed.2004.06.006","article-title":"Evolving role of positron emission tomography in the management of patients with inflammatory and other benign disorders","volume":"34","author":"El-Haddad","year":"2004","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0095","first-page":"104","article-title":"Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake","volume":"35","author":"Kubota","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.2967\/jnumed.109.074294","article-title":"Do hyperglycemia and diabetes affect the incidence of false-negative 18F-FDG PET\/CT studies in patients evaluated for infection or inflammation and cancer? A comparative analysis","volume":"51","author":"Rabkin","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0105","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.117.192062","article-title":"Does antibiotic treatment affect the diagnostic accuracy of FDG PET\/CT studies in patients with suspected infectious processes?","author":"Kagna","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.carj.2014.08.004","article-title":"Fluorodeoxyglucose positron emission tomography\/computed tomography interpretation criteria for assessment of antibiotic treatment response in pyogenic spine infection","volume":"66","author":"Riccio","year":"2015","journal-title":"Can Assoc Radiol J"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0115","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1097\/BRS.0b013e3181b1fd33","article-title":"Prediction of residual disease of spine infection using F-18 FDG PET\/CT","volume":"34","author":"Kim","year":"2009","journal-title":"Spine"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2017.10.004_bib0120","first-page":"17","article-title":"Role of (18)F-FDG PET\/CT in the evaluation of response to antibiotic therapy in patients affected by infectious spondylodiscitis","volume":"18","author":"Niccoli Asabella","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0125","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2967\/jnumed.115.156265","article-title":"(18)F-FDG PET\/CT for therapy control in vascular graft infections: A first feasibility study","volume":"56","author":"Husmann","year":"2015","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0130","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1365-3156.2008.02042.x","article-title":"Timing of default from tuberculosis treatment: A systematic review","volume":"13","author":"Kruk","year":"2008","journal-title":"Trop Med Int Health"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0135","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1056\/NEJMra1413919","article-title":"Treatment of tuberculosis","volume":"373","author":"Horsburgh","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0140","doi-asserted-by":"crossref","first-page":"724","DOI":"10.5588\/ijtld.12.0083","article-title":"The chemotherapy of tuberculosis: Past, present and future","volume":"16","author":"Mitchison","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1407426","article-title":"Four-month moxifloxacin-based regimens for drug-sensitive tuberculosis","volume":"371","author":"Gillespie","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0150","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJMoa1315817","article-title":"A four-month gatifloxacin-containing regimen for treating tuberculosis","volume":"371","author":"Merle","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067030","article-title":"Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients","volume":"8","author":"Jawahar","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0160","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1314210","article-title":"High-dose rifapentine with moxifloxacin for pulmonary tuberculosis","volume":"371","author":"Jindani","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1164\/rccm.200904-0536OC","article-title":"Shortening treatment in adults with noncavitary tuberculosis and 2-month culture conversion","volume":"180","author":"Johnson","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0170","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(11)61062-3","article-title":"The global rise of extensively drug-resistant tuberculosis: Is the time to bring back sanatoria now overdue?","volume":"379","author":"Dheda","year":"2012","journal-title":"Lancet"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0175","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4049\/jimmunol.1700231","article-title":"Positron emission tomography imaging of macaques with tuberculosis identifies temporal changes in granuloma glucose metabolism and integrin \u03b14\u03b21-expressing immune cells","volume":"199","author":"Mattila","year":"2017","journal-title":"J Immunol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0180","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0037-198X(79)90006-3","article-title":"Pathology of tuberculosis","volume":"14","author":"Pratt","year":"1979","journal-title":"Semin Roentgenol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1183\/09031936.04.00087304","article-title":"Response of pulmonary tuberculomas to anti-tuberculos treatment","volume":"23","author":"Lee","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0190","series-title":"Tuberculosis","first-page":"373","author":"Rom","year":"1996"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0195","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0002-9343(77)90346-1","article-title":"Clinical and roentgenographic spectrum of pulmonary tuberculosis in the adult","volume":"62","author":"Khan","year":"1977","journal-title":"Am J Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0200","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0096-5588(20)31545-2","article-title":"Pulmonary tuberculomas: Pathogenesis, diagnosis, and management","volume":"20","author":"Culver","year":"1950","journal-title":"J Thorac Surg"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF03165391","article-title":"FDG-PET in infectious lesions: The detection and assessment of lesion activity","volume":"10","author":"Ichiya","year":"1996","journal-title":"Ann Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0210","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nucmedbio.2017.04.003","article-title":"Clinical usefulness of 18F-FDG PET\/CT for initial staging and assessment of treatment efficacy in patients with lymph node tuberculosis","volume":"50","author":"Lefebvre","year":"2017","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0215","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1097\/RLU.0000000000001102","article-title":"18F-FDG PET\/CT in the initial assessment and for follow-up in patients with tuberculosis","volume":"41","author":"Stelzmueller","year":"2016","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0220","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/0972-3919.172365","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography\/computed tomography imaging in response monitoring of extra-pulmonary tuberculosis","volume":"31","author":"Arbind","year":"2016","journal-title":"Indian J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0225","doi-asserted-by":"crossref","first-page":"17507","DOI":"10.1038\/srep17507","article-title":"Within patient microevolution of Mycobacterium tuberculosis correlates with heterogeneous responses to treatment","volume":"5","author":"Liu","year":"2015","journal-title":"Sci Rep"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0230","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/imr.12252","article-title":"Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses","volume":"264","author":"Lenaerts","year":"2015","journal-title":"Immunol Rev"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0235","doi-asserted-by":"crossref","first-page":"265ra166","DOI":"10.1126\/scitranslmed.3009501","article-title":"PET\/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis","volume":"6","author":"Chen","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0240","doi-asserted-by":"crossref","first-page":"265ra167","DOI":"10.1126\/scitranslmed.3009500","article-title":"PET\/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis","volume":"6","author":"Coleman","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0245","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/0972-3919.142635","article-title":"Pancreatic tuberculosis: Evaluation of therapeutic response using F-18 fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography","volume":"29","author":"Santhosh","year":"2014","journal-title":"Indian J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0250","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1164\/rccm.201311-1976LE","article-title":"Increased cellular activity in thoracic lymph nodes in early human latent tuberculosis infection","volume":"189","author":"Ghesani","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0255","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1007\/s00586-014-3483-8","article-title":"Potential role of F18 FDG PET-CT as an imaging biomarker for noninvasive evaluation in uncomplicated skeletal tuberculosis: A prospective clinical observational study","volume":"23","author":"Dureja","year":"2014","journal-title":"Eur Spine J"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0260","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1128\/AAC.00277-13","article-title":"Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens","volume":"57","author":"Lin","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0265","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1128\/AAC.00531-12","article-title":"Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(18)F]2-fluoro-deoxy-d-glucose positron emission tomography and computed tomography","volume":"56","author":"Via","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0270","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.5588\/ijtld.12.0010","article-title":"(18)F-FDG PET\/CT in tuberculosis: An early non-invasive marker of therapeutic response","volume":"16","author":"Martinez","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0275","doi-asserted-by":"crossref","first-page":"136","DOI":"10.4103\/0972-3919.110712","article-title":"Assessment of early response to treatment in extrapulmonary tuberculosis: Role of FDG-PET","volume":"27","author":"Yadla","year":"2012","journal-title":"Indian J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s13139-011-0114-8","article-title":"Monitoring therapeutic response in a case of extrapulmonary tuberculosis by serial F-18 FDG PET\/CT","volume":"46","author":"Park","year":"2012","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0285","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00259-012-2115-y","article-title":"Tuberculous lymphadenitis: FDG PET and CT findings in responsive and nonresponsive disease","volume":"39","author":"Sathekge","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0290","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2967\/jnumed.110.083709","article-title":"Use of 18F-FDG-PET to predict response to first-line tuberculostatics in HIV-associated tuberculosis","volume":"52","author":"Sathekge","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0295","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3109\/02841851.2010.504744","article-title":"FDG PET\/CT for therapeutic response monitoring in multi-site non-respiratory tuberculosis","volume":"51","author":"Tian","year":"2010","journal-title":"Acta Radiol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0300","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4103\/0022-3859.68639","article-title":"FDG-PET\/CT in diagnosis and early response evaluation of extra-pulmonary tuberculosis in a patient with aplastic anemia","volume":"56","author":"Harisankar","year":"2010","journal-title":"J Postgrad Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0305","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00259-008-1009-5","article-title":"Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis","volume":"36","author":"Demura","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0310","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1128\/AAC.00789-09","article-title":"Noninvasive pulmonary [18F]-2-fluoro-deoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment","volume":"53","author":"Davis","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RLU.0b013e31815c5128","article-title":"Evaluation of therapeutic response of tuberculoma using F-18 FDG positron emission tomography","volume":"33","author":"Park","year":"2008","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0320","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.tube.2007.05.013","article-title":"Mycobacterium tuberculosis infection in patients with cancer, the role of 18-fluorodeoxyglucose positron emission tomography for diagnosis and monitoring treatment response","volume":"87","author":"Hofmeyr","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0325","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2967\/jnumed.114.144634","article-title":"Imaging the evolution of reactivation pulmonary tuberculosis in mice using 18F-FDG PET","volume":"55","author":"Murawski","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0330","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1128\/AAC.00217-12","article-title":"Evaluation of a mouse model of necrotic granuloma formation using C3HeB\/FeJ mice for testing of drugs against Mycobacterium tuberculosis","volume":"56","author":"Driver","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0335","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1128\/AAC.02565-14","article-title":"Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas","volume":"58","author":"Irwin","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0340","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AAC.05208-11","article-title":"Pharmacokinetic evaluation of the penetration of antituberculosis agents in rabbit pulmonary lesions","volume":"56","author":"Kjellsson","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0345","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.3892\/ol.2015.3709","article-title":"Interpretation of a heterogeneous radiological response as tumor heterogeneity or a non-tumor diagnosis: A case report","volume":"10","author":"Ryu","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0350","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/nm.4177","article-title":"Persisting PET-CT lesion activity and M. tuberculosis mRNA after pulmonary tuberculosis cure","volume":"2","author":"Malherbe","year":"2016","journal-title":"Nat Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0355","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2466-13-14","article-title":"18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: A case series","volume":"13","author":"Heysell","year":"2013","journal-title":"BMC Pulm Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0360","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.semnuclmed.2016.12.003","article-title":"18F-FDG-PET\/CT imaging of thoracic and extrathoracic tuberculosis in children","volume":"47","author":"Pelletier-Galarneau","year":"2017","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0365","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijid.2016.11.003","article-title":"Imaging in extrapulmonary tuberculosis","volume":"56","author":"Gambhir","year":"2017","journal-title":"Int J Infect Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0370","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1586\/17476348.2016.1166960","article-title":"Assessment of treatment response in tuberculosis","volume":"10","author":"Rockwood","year":"2016","journal-title":"Expert Rev Respir Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0375","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijid.2014.12.007","article-title":"Imaging in tuberculosis","volume":"32","author":"Skoura","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0380","doi-asserted-by":"crossref","first-page":"a017814","DOI":"10.1101\/cshperspect.a017814","article-title":"Imaging in tuberculosis","volume":"5","author":"Bomanji","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0385","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MCP.0000000000000043","article-title":"Advances in imaging of tuberculosis: The role of 18F-FDG PET and PET\/CT","volume":"20","author":"Vorster","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0390","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MNM.0b013e3283528a7c","article-title":"Nuclear medicine imaging in tuberculosis using commercially available radiopharmaceuticals","volume":"33","author":"Sathekge","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0395","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13139-016-0422-0","article-title":"The role of nuclear medicine in the staging and management of human immune deficiency virus infection and associated diseases","volume":"51","author":"Ankrah","year":"2017","journal-title":"Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0400","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s00259-013-2671-9","article-title":"Differentiation of HIV-associated lymphoma from HIV-associated reactive adenopathy using quantitative FDG PET and symmetry","volume":"41","author":"Mhlanga","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0405","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00259-014-2701-2","article-title":"Differentiation of HIV-associated lymphoma from HIV-reactive adenopathy using quantitative FDG-PET and symmetry","volume":"41","author":"Sathekge","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0410","doi-asserted-by":"crossref","DOI":"10.2174\/1381612824666171213101648","article-title":"The role of PET in monitoring therapy in fungal infections","author":"Ankrah","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0415","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1053\/j.semnuclmed.2016.12.005","article-title":"Nuclear medicine imaging in pediatric infection or chronic inflammatory diseases","volume":"47","author":"Signore","year":"2017","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0420","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.clinimag.2013.02.011","article-title":"18F-fluorodeoxyglucose positron emission tomography for the initial evaluation and monitoring of therapeutic response in bilateral adrenal histoplasmosis","volume":"37","author":"Tsai","year":"2013","journal-title":"Clin Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0425","first-page":"68","article-title":"(18)F-FDG PET\/CT contribution to diagnosis and treatment response of rhino-orbital-cerebral mucormycosis","volume":"18","author":"Altini","year":"2015","journal-title":"Hell J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0430","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003072-200103000-00011","article-title":"Therapy monitoring in aspergillosis using F-18 FDG positron emission tomography","volume":"26","author":"Franzius","year":"2001","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0435","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2010.03301.x","article-title":"Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections","volume":"17","author":"Hot","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0440","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jns.2013.08.010","article-title":"Atypical clinical and radiological presentation of cryptococcal choroid plexitis in an immunocompetent woman","volume":"334","author":"Dubbioso","year":"2013","journal-title":"J Neurol Sci"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0445","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/RLU.0000000000000400","article-title":"18F-FDG PET as a monitoring tool to assess treatment response in bilateral adrenal histoplasmosis","volume":"39","author":"Kasaliwal","year":"2014","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0450","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00059-012-3715-9","article-title":"Fungal endocarditis of a bioprosthetic aortic valve. Pharmacological treatment of a Candida parapsilosis endocarditis","volume":"38","author":"Wallner","year":"2013","journal-title":"Herz"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0455","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00277-011-1204-5","article-title":"FDG-PET can evaluate the treatment for fungal liver abscess much earlier than other imagings","volume":"90","author":"Miyazaki","year":"2011","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0460","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/RLU.0b013e3181a7cfba","article-title":"Hepatosplenic candidiasis imaged with F-18 FDG PET\/CT","volume":"34","author":"Teyton","year":"2009","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0465","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1007\/s00259-009-1255-1","article-title":"Monitoring of systemic candidiasis by 18F-FDG PET\/CT","volume":"36","author":"Avet","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0470","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/RLU.0b013e3181e4db84","article-title":"Utility of FDG PET\/CT in guiding antifungal therapy in acute leukemia patients with chronic disseminated candidiasis","volume":"35","author":"Xu","year":"2010","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0475","doi-asserted-by":"crossref","first-page":"e370","DOI":"10.1097\/RLU.0b013e3182867d13","article-title":"Utility of 18F-FDG PET\/CT in diagnosis and management of mucormycosis","volume":"38","author":"Liu","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0480","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13693780701639546","article-title":"The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections","volume":"46","author":"Chamilos","year":"2008","journal-title":"Med Mycol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0485","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.actatropica.2009.11.001","article-title":"Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans","volume":"114","author":"Brunetti","year":"2010","journal-title":"Acta Trop"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0490","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2008.03.023","article-title":"Alveolar echinococcosis: From a deadly disease to a relatively well-controlled infection. Relative survival and economic analysis in Switzerland over the past 35 years","volume":"48","author":"Torgerson","year":"2008","journal-title":"J Hepatol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0495","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1007\/s00261-006-9173-1","article-title":"Assessment of disease activity in alveolar echinococcosis: A comparison of contrast enhanced ultrasound, three-phase helical CT and [18F] fluorodeoxyglucose positron emission tomography","volume":"32","author":"Ehrhardt","year":"2007","journal-title":"Abdom Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0500","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2967\/jnumed.112.109942","article-title":"The role of delayed 18F-FDG PET imaging in the follow-up of patients with alveolar echinococcosis","volume":"54","author":"Caoduro","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0505","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/hep.20078","article-title":"Structured treatment interruption in patients with alveolar echinococcosis","volume":"39","author":"Reuter","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0510","doi-asserted-by":"crossref","first-page":"e0003964","DOI":"10.1371\/journal.pntd.0003964","article-title":"Outcome after discontinuing long-term benzimidazole treatment in 11 patients with non-resectable alveolar echinococcosis with negative FDG-PET\/CT and anti-EmII\/3-10 serology","volume":"9","author":"Ammann","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0515","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/nrendo.2010.199","article-title":"Lipodystrophy: Pathophysiology and advances in treatment","volume":"7","author":"Fiorenza","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0520","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/COH.0000000000000075","article-title":"Update on metabolic issues in HIV patients","volume":"9","author":"Calvo","year":"2014","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0525","doi-asserted-by":"crossref","first-page":"R185","DOI":"10.1530\/EJE-13-0967","article-title":"Metabolic and body composition effects of newer antiretrovirals in HIV infected patients","volume":"170","author":"Srinivasa","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0530","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MNM.0b013e3283359058","article-title":"Evaluation of glucose uptake by skeletal muscle tissue and subcutaneous fat in HIV-infected patients with and without lipodystrophy using FDG- PET","volume":"31","author":"Sathekge","year":"2010","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0535","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3851\/IMP2420","article-title":"Increase FDG uptake associated with reduced extremity fat in HIV patients","volume":"18","author":"Torriaini","year":"2013","journal-title":"Antivir Ther"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0540","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/MNM.0b013e32834f9b14","article-title":"Metabolic assessment of intracranial tuberculomas using 11C-methionine and 18F-FDG PET\/CT","volume":"33","author":"D'Souza","year":"2012","journal-title":"Nucl Med Commun"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0545","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2174\/1876388X01406010017","article-title":"Imaging of pulmonary tuberculosis with 18f-fluoro-deoxy-glucose and 18F-ethylcholine","volume":"6","author":"Vorster","year":"2014","journal-title":"Open Nucl Med J"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0550","article-title":"68Ga-citrate PET\/CT in tuberculosis: A pilot study","author":"Vorster","year":"2014","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0555","doi-asserted-by":"crossref","first-page":"e1004568","DOI":"10.1371\/journal.ppat.1004568","article-title":"An iron-mimicking, Trojan horse-entering fungi\u2014Has the time come for molecular imaging of fungal infections?","volume":"11","author":"Haas","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0560","doi-asserted-by":"crossref","first-page":"E1026","DOI":"10.1073\/pnas.1518836113","article-title":"ImmunoPET\/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo","volume":"113","author":"Rolle","year":"2016","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0565","doi-asserted-by":"crossref","first-page":"8598","DOI":"10.1039\/C6OB01734G","article-title":"Deoxyfluoro-d-trehalose (FDTre) analogues as potential PET probes for imaging mycobacterial infection","volume":"14","author":"Rundell","year":"2016","journal-title":"Org Biomol Chem"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0570","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/00003072-199912000-00006","article-title":"Value of Ga-67 SPECT in monitoring the effects of therapy in invasive aspergillosis of the sphenoid sinus","volume":"24","author":"Tzen","year":"1999","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0575","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/snuc.2002.124178","article-title":"Gallium and other agents in diseases of the lung","volume":"32","author":"Schuster","year":"2002","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0580","first-page":"233","article-title":"Technetium-99m-MIBI scintigraphy in pulmonary tuberculosis","volume":"37","author":"Onsel","year":"1996","journal-title":"J Nucl Med"},{"issue":"suppl 1","key":"10.1053\/j.semnuclmed.2017.10.004_bib0585","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.3109\/13693786.2010.508188","article-title":"Radiotracers for fungal infection imaging","volume":"49","author":"Lupetti","year":"2011","journal-title":"Med Mycol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0590","first-page":"155","article-title":"Synthesis and evaluation of a 99mTechnetium labeled chitin-binding protein as potential specific radioligand for the detection of fungal infections in mice","volume":"50","author":"Siaens","year":"2006","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0595","first-page":"1209","article-title":"[123]I-Labeled chitinase as specific radioligand for in vivo detection of fungal infections in mice","volume":"45","author":"Siaens","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0600","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2967\/jnumed.113.128397","article-title":"Preclinical evaluation of 68Ga-labeled 1,4,7-triazacyclononane-1,4,7-triacetic acid-ubiquicidin as a radioligand for PET infection imaging","volume":"55","author":"Ebenhan","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0605","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.nucmedbio.2014.02.001","article-title":"Peptide synthesis, characterization and 68Ga-radiolabeling of NOTA-conjugated ubiquicidin fragments for prospective infection imaging with PET\/CT","volume":"41","author":"Ebenhan","year":"2014","journal-title":"Nucl Med Biol"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0610","doi-asserted-by":"crossref","DOI":"10.2967\/jnumed.117.191635","article-title":"Metabolic Imaging of Infection","author":"Lawal","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1053\/j.semnuclmed.2017.10.004_bib0615","doi-asserted-by":"crossref","first-page":"688","DOI":"10.3389\/fimmu.2017.00688","article-title":"Applying precision medicine and immunotherapy advances from oncology to host-directed therapies for infectious diseases","volume":"8","author":"Mahon","year":"2017","journal-title":"Front Immunol"}],"container-title":["Seminars in Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299817300995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001299817300995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T19:07:27Z","timestamp":1603307247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001299817300995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":122,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S0001299817300995"],"URL":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2017.10.004","relation":{},"ISSN":["0001-2998"],"issn-type":[{"value":"0001-2998","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring Response to Therapy","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nuclear Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.semnuclmed.2017.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}